Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-01-01 @ 9:45 PM
Study NCT ID:
NCT05107856
Status:
TERMINATED
Last Update Posted:
2024-01-31
First Post:
2021-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
Sponsor:
Prelude Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-25
First Submit QC Date:
None
Study First Post Date:
2021-11-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-29
Last Update Post Date:
2024-01-31
Last Update Post Date Type:
ACTUAL